aacc beginnings
In 1950, the AACC had perceived the need to underscore the competency of adequately trained and experienced clinical chemists by helping to form the American Board of Clinical Chemistry (ABCC) to certify practitioners of clinical chemistry. Those who were certified had to hold a PhD degree or its equivalent and were certified by virtue of a rigorous written examination. By the 1960s, it was recognized that the profession included a larger corps of qualified professionals, many of them at the BS and MS levels, who also were vital to clinical chemistry. As a result, the National Registry in Clinical Chemistry (NRCC) was created in 1967 to certify these professionals also. Pivotally involved in its formation were AACC, ABCC, ACS, The American Institute of Chemists, and American Society of Biological Chemists. While such credentialing programs greatly assisted in elevating the clinical chemistry profession to new levels of public recognition, more positive efforts were needed to coalesce the profession, to keep its practitioners better informed scientifically, to provide a forum for meeting and exchanging professional and scientific information, and to mount an effort to foster better public recognition as well as secure a measure of legal recognition.
AACC served to fulfill most of the scientific needs of the profession, but it lacked the means to achieve full public or legal awareness of clinical chemistry's importance to healthcare. Leading the way in this area was the ACS, which had a strong Committee on Clinical Chemistry reporting to the Society's Board of Directors. As such, the Committee was in a position to influence ACS policy and also to gain attention in the regulatory and legislative arena. It did so successfully by securing ACS Board approval of national policy statements relating to regulation of the clinical chemistry profession, by endorsement of licensure or other appropriate means of regulation (e.g., registration and certification) of its practitioners, and by taking the public position that the practice of clinical chemistry was not the practice of medicine-a contention then vocally emphasized by some clinical pathologists who operated clinical laboratories. However, the issue was laid to rest in 1969 after a complaint by the federal government in the US District Court for the Northern District of Illinois against the College of American Pathologists (CAP), citing violation of the restraint of trade provisions of the Sherman Antitrust Act of 1890. This led to a consent decree enjoining the CAP and its members from preventing ownership and (or) operation of or specimen referral to clinical laboratories owned by other than physicians.
Another policy statement dealing with clinical chemistry practice-this one concerned with proficiency testing-also was issued by the ACS Board. These statements dealt with regulation, averring that the practice of clinical chemistry was not the practice of medicine, and proficiency testing by clinical laboratories became the foundation for a strong effort to promote state licensure of clinical chemistry laboratories, both nationally and locally.
clinical laboratory problems
The adoption of policy statements on regulation of clinical laboratory practice and proficiency testing plus the consent decree relating to the CAP stemmed from the rapid growth of clinical laboratories to assist in the diagnostic process after World War II. With such growth, though, First Executive Director of AACC, 1968 AACC, -1970 At the time, clinical pathologists were regarded in the medical profession as the most knowledgeable practitioners capable of handling specimens from the human body. However, there was a shortage of these practitioners, and their high salaries tempted some to lend their names as directors of non-hospital-associated laboratories, even though they did not actively participate at such installations. Too, some more-outspoken clinical pathologists strove to press for acceptance of the principle that clinical laboratory testing was the practice of medicine and should be performed only under the direction of such medical practitioners.
Regulations. Such developments had led California earlier to become the first jurisdiction to require that clinical laboratory technologists (e.g., clinical chemists, clinical microbiologists, bioanalysts) be licensed. After the national "sink test" allegations in the media, New York City also mandated proficiency testing for all clinical laboratories within its jurisdiction.
These efforts ultimately contributed substantially to passage by Congress of the Clinical Laboratories Improvement Act of 1967 (CLIA), and to the enactment of clinical laboratory licensure laws in several states. Granted, CLIA regulated only clinical laboratories engaged in interstate commerce, but by 1974 other federal legislation, setting up Medicare, had the capability of dealing with virtually all laboratories through its ability to influence proficiency testing by virtue of the economic sanctions it could exercise over participating laboratories in the new national healthcare program.
In the main, efforts to push for state licensure were orchestrated by William B. Mason (Fig. 1) 
aacc administration
The main task was that of converting AACC from its existing volunteer management system to a staffed operation. This entailed supervision of such membership activities as member record maintenance, distribution of dues bills, participation in arranging and managing the annual meeting and associated exhibits program, assisting committees with their agendas and missions, and working with the Council and Board of Directors and implementing their directives. To achieve this transition required significant administrative changes. With the cooperation of the ACS, membership records and dues billings were now handled by the National Office rather than by the elected volunteer officers. A transition was made from an academic to a calendar year, thereby giving President Robert S. Melville , 1967 -1968 . Clinical Chemistry 43, No. 7, 1997 ( Fig. 2 ) the opportunity to preside at both the 1969 and 1970 national meetings in Denver and Buffalo. He recalls that the 1969 meeting was particularly eventful when all the Association members and other guests in the Denver Hilton were forced out into the street in the wee hours because of a kitchen fire. Seeing members in their night clothes provided much conversational fodder for the balance of the meeting, he notes. President Melville was also centrally involved in the direction of the new National Office. At about the same time, the Association's committee structure was revamped and the Constitution and Bylaws were revised significantly, being reissued on January 1, 1971.
Another major change occurred when the Board of Directors decided to make Clinical Chemistry a self-published periodical. Previously, the journal had been published under contract with Harper & Row Publishers in New York. Harold Appleton, Managing Editor, and Max Friedman, Chairman of the Editorial Board, both were involved in this transition to self-publication and continued to serve in their respective positions thereafter. Layout of copy, pagination, proof reading, and other tasks related to actual preparation of each issue for printing were now handled by the ACS editorial staff. I also wrote the regular journal column "Clinical Chemistry News" to keep members informed about professional and administrative matters. The Association contracted with Earl Scherago Associates of New York City to help expand advertising and thus increase revenue. Scherago later handled booth space sales for AACC's annual meetings.
During this era, volunteer officers and others continued to play an important role in the administrative affairs of the Association, and my staff never included more than one other full-time equivalent person in the National Office to serve both AACC and NRCC.
A major AACC mission continued to be that of striving (Fig. 3) . The responsibilities of AACC Executive Director grew steadily, leading to increasing allocations of my time to AACC. During that period, I helped the Association grow in membership, became more involved in support functions for Clinical Chemistry, continued to edit the "Clinical Chemistry News" section of the journal, and launched an effort for local sections to play a more prominent role in AACC activities. In recognition of these contributions to clinical chemistry, in 1970 I was offered and accepted membership in AACC.
During the 1968 -70 era, my involvement as chief administrative officer grew from a 10% commitment to 50% by 1970. It then became apparent that the Association should take its next major step towards an independently Mason (1967-68) , George T. Lewis (1968 -69) , and Robert S. Melville (1969 -70) provided ongoing guidance to the office headquarters and its modest staff operations in the ACS building. Also, national/annual meetings began to grow in stature and registrations. In 1968, the Association met in Washington, DC. A year later (as noted previously), it convened in Denver, CO, and in 1970 held its meeting in Buffalo, NY.
Membership data for those years are not conveniently retrievable, though my impression is that significant membership growth also began thereafter, increasing from ϳ2500 members in 1968 to ϳ11 000 in 1996. Financial data also are unavailable, all transactions having been handled by the elected Treasurer, Joseph Benotti, as the 1960s came to an end, but were likely quite modest compared with the current budget of some $11 million.
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